vs
Side-by-side financial comparison of LINKBANCORP, Inc. (LNKB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $46.0M, roughly 1.6× LINKBANCORP, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.6%).
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
LNKB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.0M | $75.5M |
| Net Profit | $2.9M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 8.5% | 22.7% |
| Net Margin | 6.4% | — |
| Revenue YoY | 7.3% | 27.7% |
| Net Profit YoY | -61.2% | — |
| EPS (diluted) | $0.08 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.0M | $75.5M | ||
| Q3 25 | $44.8M | $54.5M | ||
| Q2 25 | $42.3M | $52.4M | ||
| Q1 25 | $53.4M | $46.0M | ||
| Q4 24 | $42.9M | $59.1M | ||
| Q3 24 | $42.9M | $80.5M | ||
| Q2 24 | $41.3M | $47.1M | ||
| Q1 24 | $40.5M | $43.8M |
| Q4 25 | $2.9M | — | ||
| Q3 25 | $7.8M | $8.8M | ||
| Q2 25 | $7.4M | $5.9M | ||
| Q1 25 | $15.3M | $3.0M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $7.1M | $20.3M | ||
| Q2 24 | $5.8M | $-4.5M | ||
| Q1 24 | $5.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 8.5% | 22.7% | ||
| Q3 25 | 22.3% | 17.6% | ||
| Q2 25 | 22.4% | 12.7% | ||
| Q1 25 | 36.0% | 8.7% | ||
| Q4 24 | 22.6% | 22.6% | ||
| Q3 24 | 21.3% | 27.4% | ||
| Q2 24 | 18.0% | -4.6% | ||
| Q1 24 | 18.1% | -5.3% |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 17.5% | 16.2% | ||
| Q2 25 | 17.5% | 11.2% | ||
| Q1 25 | 28.7% | 6.5% | ||
| Q4 24 | 17.7% | — | ||
| Q3 24 | 16.5% | 25.2% | ||
| Q2 24 | 14.1% | -9.6% | ||
| Q1 24 | 14.1% | -11.0% |
| Q4 25 | $0.08 | $0.26 | ||
| Q3 25 | $0.21 | $0.17 | ||
| Q2 25 | $0.20 | $0.12 | ||
| Q1 25 | $0.41 | $0.06 | ||
| Q4 24 | $0.21 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.16 | $-0.09 | ||
| Q1 24 | $0.15 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.3M | $97.5M |
| Total DebtLower is stronger | $177.3M | $22.7M |
| Stockholders' EquityBook value | $306.4M | $130.3M |
| Total Assets | $3.1B | $216.3M |
| Debt / EquityLower = less leverage | 0.58× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.3M | $97.5M | ||
| Q3 25 | $194.2M | $94.4M | ||
| Q2 25 | $155.1M | $96.0M | ||
| Q1 25 | $220.2M | $93.2M | ||
| Q4 24 | $166.1M | $101.0M | ||
| Q3 24 | $191.2M | $96.7M | ||
| Q2 24 | $181.7M | $96.8M | ||
| Q1 24 | $172.3M | $107.2M |
| Q4 25 | $177.3M | $22.7M | ||
| Q3 25 | $102.3M | $34.0M | ||
| Q2 25 | $102.3M | $45.3M | ||
| Q1 25 | $102.7M | $56.7M | ||
| Q4 24 | $112.5M | $68.0M | ||
| Q3 24 | $102.4M | $79.3M | ||
| Q2 24 | $102.3M | $90.7M | ||
| Q1 24 | $102.2M | $102.0M |
| Q4 25 | $306.4M | $130.3M | ||
| Q3 25 | $305.5M | $115.3M | ||
| Q2 25 | $298.0M | $104.7M | ||
| Q1 25 | $294.1M | $97.1M | ||
| Q4 24 | $280.2M | $92.1M | ||
| Q3 24 | $277.4M | $71.1M | ||
| Q2 24 | $271.4M | $48.5M | ||
| Q1 24 | $268.2M | $51.0M |
| Q4 25 | $3.1B | $216.3M | ||
| Q3 25 | $3.1B | $202.9M | ||
| Q2 25 | $2.9B | $194.9M | ||
| Q1 25 | $2.9B | $196.2M | ||
| Q4 24 | $2.9B | $213.3M | ||
| Q3 24 | $2.9B | $220.7M | ||
| Q2 24 | $2.9B | $205.0M | ||
| Q1 24 | $2.8B | $214.1M |
| Q4 25 | 0.58× | 0.17× | ||
| Q3 25 | 0.33× | 0.30× | ||
| Q2 25 | 0.34× | 0.43× | ||
| Q1 25 | 0.35× | 0.58× | ||
| Q4 24 | 0.40× | 0.74× | ||
| Q3 24 | 0.37× | 1.12× | ||
| Q2 24 | 0.38× | 1.87× | ||
| Q1 24 | 0.38× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | $14.4M |
| Free Cash FlowOCF − Capex | $23.8M | $14.4M |
| FCF MarginFCF / Revenue | 51.7% | 19.1% |
| Capex IntensityCapex / Revenue | 3.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 8.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.3M | $14.4M | ||
| Q3 25 | $23.6M | $9.7M | ||
| Q2 25 | $6.3M | $14.1M | ||
| Q1 25 | $2.6M | $3.6M | ||
| Q4 24 | $25.4M | $15.6M | ||
| Q3 24 | $14.0M | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $-771.0K | $11.2M |
| Q4 25 | $23.8M | $14.4M | ||
| Q3 25 | $23.2M | $9.7M | ||
| Q2 25 | $6.1M | $14.1M | ||
| Q1 25 | $2.2M | $3.6M | ||
| Q4 24 | $22.6M | $15.6M | ||
| Q3 24 | $13.1M | $11.0M | ||
| Q2 24 | $6.3M | $1.0M | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | 51.7% | 19.1% | ||
| Q3 25 | 51.8% | 17.7% | ||
| Q2 25 | 14.5% | 26.8% | ||
| Q1 25 | 4.2% | 7.7% | ||
| Q4 24 | 52.6% | 26.4% | ||
| Q3 24 | 30.5% | 13.7% | ||
| Q2 24 | 15.3% | 2.1% | ||
| Q1 24 | -3.0% | — |
| Q4 25 | 3.2% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 6.7% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
| Q4 25 | 8.59× | — | ||
| Q3 25 | 3.01× | 1.10× | ||
| Q2 25 | 0.85× | 2.41× | ||
| Q1 25 | 0.17× | 1.21× | ||
| Q4 24 | 3.35× | — | ||
| Q3 24 | 1.97× | 0.54× | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | -0.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
